Anti-CD44 DNA Aptamers Selectively Target Cancer Cells-Reference-Cited by-同舟云学术

Anti-CD44 DNA Aptamers Selectively Target Cancer Cells

Published:2020-10-01 Issue:5 Volume:30 Page:289-298
ISSN:2159-3337
Container-title:Nucleic Acid Therapeutics
language:en
Short-container-title:Nucleic Acid Therapeutics

Author:

Pęcak Aleksandra¹²,Skalniak Łukasz³,Pels Katarzyna¹,Książek Mirosław²,Madej Mariusz²,Krzemień Dobrosława¹²³,Malicki Stanisław²,Władyka Benedykt¹,Dubin Adam¹,Holak Tad A.³,Dubin Grzegorz²

Affiliation:

1. Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland.

2. Malopolska Centre of Biotechnology, Jagiellonian University, Krakow, Poland.

3. Faculty of Chemistry, Jagiellonian University, Krakow, Poland.

Publisher

Mary Ann Liebert Inc

Subject

Drug Discovery,Genetics,Molecular Biology,Molecular Medicine,Biochemistry

Link

https://www.liebertpub.com/doi/pdf/10.1089/nat.2019.0833

Reference58 articles.

1. CD44 and Its Interaction with Extracellular Matrix

2. The biology and role of CD44 in cancer progression: therapeutic implications

3. CD44 in Cancer

4. Involvement of CD44, a molecule with a thousand faces, in cancer dissemination

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostic application of aptamers against leukemia, multiple myeloma and lymphoma: A review;Journal of Drug Delivery Science and Technology;2024-10

2. Self-powered biosensing platform for Highly sensitive detection of soluble CD44 protein;Talanta;2024-05

3. Tumor diagnosis using carbon-based quantum dots: Detection based on the hallmarks of cancer;Bioactive Materials;2024-03

4. Selection of DNA aptamer recognizing CD44 for high-eﬃciency capture of circulating tumor cells;Talanta;2023-09

5. Aptamers against cancer drug resistance: Small fighters switching tactics in the face of defeat;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2023-08